Looking for a comprehensive metabolic health orweight loss program?

Women experiencing stubborn weight gain, PCOS, menopause-related changes, fatigue, or metabolic syndrome symptoms.

Maybe. Metabolic health is not determined by BMI alone. You may qualify if you have insulin resistance, PCOS, or other cardiometabolic risk factors.

You’ll meet with a Tia provider to discuss your full health history, symptoms, and goals. We may order labs and explore tools like nutrition changes or medication if appropriate. You’ll leave with a care plan built around your needs and goals.

We treat weight as part of a bigger picture, not just a number to fix. Our care is designed specifically for women, factoring in life stage, hormones, mental health, and more. Whether you’re navigating PCOS or exploring GLP-1s, we create a personalized, evidence-based plan and stay with you to adjust it over time.

Testing is based on what is clinically indicated and may include fasting glucose, HbA1c, insulin levels, lipid panels, thyroid labs and liver enzymes. We want to make sure we’re treating the whole you, not just the number on the scale.

Your care doesn’t stop after a single appointment. Whether you’re starting GLP-1s, tapering off of them, adjusting nutrition, or changing movement routines, we’re here with you every step of the way. You’ll have regular follow-ups to check in on your progress and update your plan.

Yes. Tia offers virtual care across CA, AZ, NY, NJ, and MA and in-person care in New York, San Francisco, Los Angeles, and Scottsdale.

Metabolic health refers to how well your body regulates blood sugar, insulin, cholesterol, blood pressure, and fat storage. When metabolic function is impaired, it can lead to insulin resistance and difficulty with weight loss.

A clinician-supervised approach to weight management that addresses hormones, metabolism, chronic stress, and underlying health conditions. It may include lab testing, lifestyle changes, and prescription medications.

Insulin resistance occurs when your cells don’t respond properly to insulin, leading to elevated blood sugar and increased fat storage. It is a major driver of weight gain, PCOS, and metabolic syndrome.

A cluster of conditions including abdominal weight gain, high blood pressure, abnormal cholesterol, and elevated blood sugar. It increases cardiovascular risk and is closely linked to insulin resistance.

Yes. Declining estrogen levels can contribute to increased visceral fat, insulin resistance, and changes in cholesterol. A women-centered plan can help address these specific shifts.

Chronic stress can increase cortisol levels, which can worsen insulin resistance and promote abdominal fat storage. Our care includes attention to stress and nervous system regulation.

Yes, if clinically appropriate. Your provider will work with you to determine if these medications are right for your body.

GLP-1 receptor agonists (such as semaglutide and tirzepatide) are medications that regulate appetite and blood sugar. They reduce hunger and improve insulin sensitivity.

They mimic a natural hormone that signals fullness to the brain and stabilizes blood sugar. This helps reduce cravings and lower caloric intake.

No. These are typically self-administered as weekly injections at home. Your provider will teach you how to safely inject. Follow-ups can be virtual or in-person.

They are FDA-approved and widely studied. At Tia, GLP-1s are viewed as one tool within a broader metabolic health strategy, not a standalone solution.

We may prescribe semaglutide or dual GIP/GLP-1 medications like tirzepatide based on your health profile.

Yes, in some cases (e.g., switching from semaglutide to tirzepatide). This must be medically supervised to ensure proper dosing adjustments.

Results vary based on metabolism, hormone balance, and lifestyle changes. Clinical trials show significant potential when combined with comprehensive care.

For some women with PCOS and insulin resistance, these medications can improve metabolic markers and support weight management.